- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
COVID-19
News 2 results
In the News · Source: The Wall Street Journal
March 6, 2020
Jason Jones comments on the coronavirus's effect on corporate anti-bribery efforts
In the News · Source: The American Lawyer
Events 3 results
Speaking Engagement
May 25, 2020
William Panlilio to Speak at Ateneo de Manila Law School’s Colloquium on Special Issues in International Law
Speaking Engagement
April 7, 2020
Robert Benson to Speak on Atlanta Business League’s COVID-19 Issues & Opportunities Webinar
Speaking Engagement
March 25, 2020
Shelby Guilbert to Speak on Perrin Conferences Webinar About Coronavirus Business Interruption
Insights 20 results
COVID-19 Vaccine Updates
February 9, 2021
FDA Advisory Committee Considers Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
Article · Source: Practical Law
July 1, 2020
Transatlantic Business Crime and Investigations June Column
Article · Source: Chamber Litigation Blog
June 10, 2020
The Nuisance of Nuisance Litigation
Article · Source: American Health Law Association
April 2, 2020
The COVID-19 Pandemic: Observations and Recommendations for Health Care Deals